Literature DB >> 9827825

CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient.

N Suzuki1, T Kudoh, N Mizue, J Watanabe, M Ikehata, M Tateno, H Ooguro, S Chiba.   

Abstract

An 11-year-old boy with severe aplastic anemia underwent unrelated BMT following TBI, antithymocyte globulin and CY. On day +23, CMV antigenemia was detected which resolved with ganciclovir. Eight days after discontinuing ganciclovir, he complained of impaired visual acuity. Ophthalmologic findings and a positive PCR study using anterior chamber fluid from the right eye confirmed the presumptive diagnosis of CMV retinitis, although CMV antigenemia and PCR studies using PBMC were then negative. He was successfully re-treated with ganciclovir. CMV retinitis should be considered even when CMV antigenemia is not present or PCR using PBMC is negative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827825     DOI: 10.1038/sj.bmt.1701441

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopy.

Authors:  Ekaterina Krauss; Abbas Agaimy; Helmut Neumann; Ulrike Schulz; Hermann Kessler; Arndt Hartmann; Markus F Neurath; Martin Raithel; Jonas Mudter
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

2.  Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia.

Authors:  K Kuriyama; S Todo; S Ikushima; N Fujii; T Yoshihara; K Tsunamoto; M Naya; M Hojo; S Hibi; A Morimoto; S Imashuku
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

3.  Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.

Authors:  Simone Cesaro; Maria Paola Boaro; Marta Pillon; Elisabetta Calore; Ivete Cermakova; Katia Perruccio; Carlo Mengoli; Chiara Messina
Journal:  Int J Hematol       Date:  2008-07-08       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.